Ethnic differences in atrial fibrillation identified using implanted cardiac devices

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 4, 2013, Pages 381-387

  Lau, Chu Pak ^a   Gbadebo, T David ^b   Connolly, Stuart J ^c   Van Gelder, Isabelle C ^d   Capucci, Alessandro ^e   Gold, Michael R ^f   Israel, Carsten W ^g   Morillo, Carlos A ^c   Siu, Chung Wah ^a   Abe, Haruhiko ^h   Carlson, Mark ^i,j   Tse, Hung Fat ^a   Hohnloser, Stefan H ^g   Healey, Jeff S ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

ⁱ ST JUDE MEDICAL   (United States)

^j NONE

more..

Author keywords

atrial fibrillation; epidemiology; pacemakers; race; risk factors

Indexed keywords

AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; ASIA; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ETHNIC GROUPS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LEAST-SQUARES ANALYSIS; MALE; MULTIVARIATE ANALYSIS; NORTH AMERICA; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TELEMETRY; TIME FACTORS;

EID: 84875819369     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12066     Document Type: Article

References (35)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Gbadebo TD, Okafor H, Darbar D,: Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J 2011; 162: 31-37.
3. Zhou Z, Hu D,: An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008; 18: 209-216.
4. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S,: Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102-107.
5. Tayebjee MH, Tyndall K, Holding S, Russell C, Graham LN, Pepper CB,: South Asians are under-represented in a clinic treating atrial fibrillation in a multicultural city in the UK. J Atrial Fibrillation 2012; 2: 1-3.
6. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P,; AFFIRM Investigators: Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149: 657-663.
7. ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ,: Irbesartan in patients with atrial fibrillation. N Engl J Med 2011; 364: 928-938.
8. Soliman EZ, Alonso A, Goff DC Jr,: Atrial fibrillation and ethnicity: The known, the unknown and the paradox. Future Cardiol 2009; 5: 547-556.
9. Bush WS, Crawford DC, Alexander C, George AL Jr, Roden DM, Ritchie MD,: Genetic variation in the rhythmonome: Ethnic variation and haplotype structure in candidate genes for arrhythmias. Pharmacogenomics 2009; 10: 1043-1053.
10. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, Fox ER, Levitzky YS, Mehra R, Kerr KF, Deo R, Sotoodehnia N, Akylbekova M, Ellinor PT, Paltoo DN, Soliman EZ, Benjamin EJ, Heckbert SR,; Candidate-Gene Association Resource (CARe) Study: European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010; 122: 2009-2015.
11. Schnabel RB, Kerr KF, Lubitz SA, Alkylbekova EL, Marcus GM, Sinner MF, Magnani JW, Wolf PA, Deo R, Lloyd-Jones DM, Lunetta KL, Mehra R, Levy D, Fox ER, Arking DE, Mosley TH, Müller-Nurasyid M, Young TR, Wichmann HE, Seshadri S, Farlow DN, Rotter JI, Soliman EZ, Glazer NL, Wilson JG, Breteler MM, Sotoodehnia N, Newton-Cheh C, Kääb S, Ellinor PT, Alonso A, Benjamin EJ, Heckbert SR,; Candidate Gene Association Resource (CARe) Atrial Fibrillation/Electrocardiography Working Group: Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: The National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet 2011; 4: 557-564.
12. Delaney JT, Jeff JM, Brown NJ, Pretorius M, Okafor HE, Darbar D, Roden DM, Crawford DC,: Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans. PLoS One 2012; 7: e32338.
13. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH,; ASSERT Investigators: Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129.
14. Hohnloser SH, Capucci A, Fain E, Gold MR, van Gelder IC, Healey J, Israel CW, Lau CP, Morillo C, Connolly SJ,; ASSERT Investigators and Committees: ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Am Heart J 2006; 152: 442-447.
15. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH,: Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004; 43: 47-52.
16. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD,: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. Circ Arrhythm Electrophysiol 2009; 2: 474-480.
17. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L,; INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-952.
18. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS,: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
19. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA,: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
20. Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF,: Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 2007; 93: 483-487.
21. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB,: Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-1644.
22. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S,; CHARM Investigators: Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2006; 152: 86-92.
23. Wolf PA, Abbott RD, Kannel WB,: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
24. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM,: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
25. Upshaw CB Jr,: Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: An electrocardiographic study. J Natl Med Assoc 2002; 94: 204-208.
26. Marcus GM, Olgin JE, Whooley M, Vittinghoff E, Stone KL, Mehra R, Hulley SB, Schiller NB,: Racial differences in atrial fibrillation prevalence and left atrial size. Am J Med 2010; 123: 375 e1- 7.
27. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR,: Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Riskin Communities (ARIC) study. Am Heart J 2009; 158: 111-117.
28. Fang K,: African Americans have markedly lower prevalence of atrial fibrillation despite higher prevalence of risk factors. Heart Rhythm 2009; 6: S46.
29. Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakaramenon S, Mairesse GH, Brandes A, Crystal E, Costantini O, Sandhu RK, Parkash R, Connolly SJ, Hohnloser SH, Healey JS,; ASSERT Steering Committee and Investigators(§ §): Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT. Heart Rhythm 2012; 9: 1241-1246.
30. Lahiri MK, Fang K, Lamerato L, Khan AM, Schuger CD,: Effect of race on the frequency of postoperative atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2011; 107: 383-386.
31. Nazeri A, Razavi M, Elayda MA, Lee VV, Massumi A, Wilson JM,: Race/ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery. Heart Rhythm 2010; 7: 1458-1463.
32. Rader F, Van Wagoner DR, Ellinor PT, Gillinov AM, Chung MK, Costantini O, Blackstone EH,: Influence of race on atrial fibrillation after cardiac surgery. Circ Arrhythm Electrophysiol 2011; 4: 644-652.
33. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, Woo D, Szaflarski J, Gebel J, Moomaw C, Pancioli A, Jauch E, Shukla R, Broderick J,: Stroke in a biracial population: The excess burden of stroke among blacks. Stroke 2004; 35: 426-431.
34. Li C, Wang F, Yang Y, Fu F, Xu C, Shi L, Li S, Xia Y, Wu G, Cheng X, Liu H, Wang C, Wang P, Hao J, Ke Y, Zhao Y, Liu M, Zhang R, Gao L, Yu B, Zeng Q, Liao Y, Yang B, Tu X, Wang QK,: Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet 2011; 129: 239-246.
35. Lau CP, Tse HF, Siu CW, Gbadebo TD,: Atrial electrical and structural remodeling: Implications for racial differences in atrial fibrillation. J Cardiovasc Electrophysiol 2012; 23: s36-s40.